SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: Roy Henninger who wrote (186)5/18/1998 6:54:00 AM
From: Henry Niman  Respond to of 550
 
LGND also in today's WSJ article on GNE's Herceptin treatment of breast cancer at wsj.com



To: Roy Henninger who wrote (186)5/18/1998 11:06:00 AM
From: Henry Niman  Respond to of 550
 
I haven't been around this morning, but CNBC just indicated that a Bear Stearns analyst would be on Market Watch. Sounds like David Molowa, and since he is going to talk about new approaches for treating cancer, I expect him to mention LGND



To: Roy Henninger who wrote (186)5/19/1998 12:37:00 AM
From: Master (Hijacked)  Read Replies (1) | Respond to of 550
 
I was excited about the Barrons article, and glad to see the spike
to $18 this AM. Unfortunately there is a big seller in SUGN that
keeps it from going ballistic from all the recent positive press.

I sold my stock this AM for a nice gain. CEO Evans-Freke
spoke at the oncology conference this weekend. Lots more to follow
so I'm holding my options... they're gonna get HOT!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News